Insider Trading Alert - VSI, SPB And LOGM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, June 13, 2014, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $159.88 to $10,372,759.29.

Highlighted Stocks Traded by Insiders:

Vitamin Shoppe (VSI) - FREE Research Report

Lamadrid Dan, who is See Remarks at Vitamin Shoppe, sold 1,767 shares at $44.85 on June 13, 2014. Following this transaction, the See Remarks owned 9,277 shares meaning that the stake was reduced by 16% with the 1,767-share transaction.

Alfonso Anthony, who is President, Nutri-Force at Vitamin Shoppe, bought 5,000 shares at $44.44 on June 13, 2014. Following this transaction, the President, Nutri-Force owned 5,000 shares meaning that the stake was boosted by 100% with the 5,000-share transaction.

The shares most recently traded at $45.20, up $0.76, or 1.68% since the insider transaction. Historical insider transactions for Vitamin Shoppe go as follows:

  • 4-Week # shares sold: 1,064
  • 12-Week # shares sold: 1,064
  • 24-Week # shares sold: 1,064

The average volume for Vitamin Shoppe has been 511,800 shares per day over the past 30 days. Vitamin Shoppe has a market cap of $1.4 billion and is part of the services sector and specialty retail industry. Shares are down 14.63% year-to-date as of the close of trading on Friday.

Vitamin Shoppe, Inc., through its subsidiaries, operates as a specialty retailer and direct marketer of nutritional products in the United States. It operates through two segments, Retail and Direct. The company has a P/E ratio of 20.5. Currently, there are 8 analysts who rate Vitamin Shoppe a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VSI - FREE

TheStreet Quant Ratings rates Vitamin Shoppe as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Vitamin Shoppe Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

The Retail Apocalypse Is About to Descend on Wall Street This Coming Week

With the Latest Drinks on Tap, 5 Ways to Stay Cool on Sizzling Days